ANTI-INTERLEUKIN-6 ANTIBODY CLAZAKIZUMAB IN LATE ANTIBODY-MEDIATED RENAL ALLOGRAFT REJECTION-MODULATION OF COMPLEMENT AT THE LEVEL OF C4 AND C3 AS A NOVEL MODE OF ACTION
TRANSPLANT INTERNATIONAL（2021）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要